HRSA will award up to $1 million to a single organization to update the Women's Preventive Services Guidelines through the new WISH program.

Soma Mandal, MD, MSCP, says removing MHT boxed warnings is overdue but calls for transparency on the FDA's product-specific ...

CMS' proposed G-codes, which experts stated would cause confusion in combination with the AMA's proposed codes, were not ...

Swanson, PhD, on a pilot in which integrative group medical visits improved menopause symptoms, knowledge, and self-efficacy.

Lisa Taylor-Swanson, PhD, on a pilot in which integrative group medical visits improved menopause symptoms, knowledge, and self-efficacy. A recap of the top video interviews from Contemporary OB/GYN's ...

Susan Reed, MD, MPH, MS, and Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, weigh in on FDA boxed warning removals for menopausal hormone therapy.

The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.

A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.

Chrisandra L. Shufelt, MD, MS, FACP, MSCP, professor and chair of the Division of General Internal Medicine and associate ...

Nearly half of menopausal sleep disruption tracks with nighttime hot flashes, while the remainder appears independent, making ...

Sleep disturbance is often the most bothersome symptom of the menopause transition, yet it frequently goes unreported unless ...